Victory Capital Management Inc. Raises Stock Position in Axcelis Technologies, Inc. $ACLS

Victory Capital Management Inc. boosted its stake in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) by 9.6% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 972,162 shares of the semiconductor company’s stock after purchasing an additional 85,407 shares during the period. Victory Capital Management Inc. owned approximately 3.14% of Axcelis Technologies worth $90,243,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of ACLS. Allspring Global Investments Holdings LLC grew its position in shares of Axcelis Technologies by 1,344.8% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 109,628 shares of the semiconductor company’s stock valued at $10,388,000 after buying an additional 102,040 shares during the last quarter. Summit Global Investments acquired a new position in Axcelis Technologies in the third quarter valued at $789,000. Squarepoint Ops LLC increased its position in shares of Axcelis Technologies by 37.0% during the second quarter. Squarepoint Ops LLC now owns 100,023 shares of the semiconductor company’s stock worth $6,971,000 after purchasing an additional 27,021 shares in the last quarter. AlphaQuest LLC acquired a new stake in shares of Axcelis Technologies during the third quarter worth about $1,347,000. Finally, Boston Partners boosted its position in shares of Axcelis Technologies by 42.3% in the 2nd quarter. Boston Partners now owns 474,043 shares of the semiconductor company’s stock valued at $33,616,000 after purchasing an additional 141,004 shares during the period. 89.98% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Axcelis Technologies

In other news, Director Jorge Titinger sold 2,000 shares of the firm’s stock in a transaction on Wednesday, December 17th. The stock was sold at an average price of $86.05, for a total value of $172,100.00. Following the completion of the transaction, the director owned 7,477 shares in the company, valued at $643,395.85. This trade represents a 21.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Gerald M. Blumenstock sold 3,034 shares of the stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $89.46, for a total transaction of $271,421.64. Following the completion of the sale, the executive vice president directly owned 18,661 shares in the company, valued at approximately $1,669,413.06. The trade was a 13.98% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 6,034 shares of company stock valued at $523,522 over the last ninety days. 0.48% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on ACLS. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Axcelis Technologies in a report on Monday, December 22nd. B. Riley Financial dropped their price target on Axcelis Technologies from $94.00 to $91.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 18th. Bank of America increased their price objective on Axcelis Technologies from $90.00 to $100.00 and gave the stock an “underperform” rating in a research report on Tuesday, January 13th. Zacks Research cut Axcelis Technologies from a “hold” rating to a “strong sell” rating in a research note on Friday, February 20th. Finally, Wall Street Zen downgraded Axcelis Technologies from a “buy” rating to a “hold” rating in a report on Saturday, January 3rd. Two equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $101.50.

Axcelis Technologies Stock Performance

Shares of ACLS opened at $86.62 on Thursday. The company has a quick ratio of 3.11, a current ratio of 4.77 and a debt-to-equity ratio of 0.04. Axcelis Technologies, Inc. has a 52-week low of $40.40 and a 52-week high of $102.93. The company has a 50-day simple moving average of $87.98 and a 200-day simple moving average of $85.88. The company has a market capitalization of $2.66 billion, a PE ratio of 22.85, a P/E/G ratio of 10.27 and a beta of 1.78.

Axcelis Technologies (NASDAQ:ACLS) last issued its earnings results on Tuesday, February 17th. The semiconductor company reported $1.49 earnings per share for the quarter, topping the consensus estimate of $1.12 by $0.37. Axcelis Technologies had a net margin of 14.33% and a return on equity of 13.73%. The company had revenue of $238.33 million for the quarter, compared to analyst estimates of $215.04 million. During the same period in the prior year, the business posted $1.54 earnings per share. The firm’s revenue for the quarter was down 5.6% compared to the same quarter last year. Axcelis Technologies has set its Q1 2026 guidance at 0.710-0.710 EPS. Equities research analysts predict that Axcelis Technologies, Inc. will post 2.55 earnings per share for the current fiscal year.

Axcelis Technologies Company Profile

Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.

The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.